| Class 2 Device Recall IMx Tacrolimus II Calibrators |  |
Date Initiated by Firm | September 19, 2003 |
Date Posted | October 24, 2003 |
Recall Status1 |
Terminated 3 on October 29, 2004 |
Recall Number | Z-0063-04 |
Recall Event ID |
27374 |
PMA Number | P970007 |
Product Classification |
unknown device name - Product Code MLM--
|
Product | IMx Tacrolimus II Calibrators, list 3C10-10; the pack contains six 4.5-mL bottles, with Calibrator A having 0 ng/mL, Calibrator B having 3 ng/mL, Calibrator C having 6 ng/mL, Calibrator D having 12 ng/mL, Calibrator E having 20 ng/mL and Calibrator F having 30 U/mL; Abbott Diagnostics, a Division of Abbott Laboratories, Abbott Park, IL 60064 |
Code Information |
list 3C10-10, lots 94165M100 and 94164M100 |
Recalling Firm/ Manufacturer |
Abbott Laboratories HPD/ADD/GPRD 100/200 Abbott Park Road Abbott Park IL 60064
|
For Additional Information Contact | Abbott Customer Support 877-422-2688 |
Manufacturer Reason for Recall | Invalid test results are being generated due to calibration errors when using calibrator lots 94165M100 and 94164M100. |
FDA Determined Cause 2 | Other |
Action | Recalled by letters dated 9/19/03 and 10/7/03. The accounts were informed of the inability to calibrate the IMx Tacrolimus II assay when using calibrator lots 94165M100 and 94164M100, and initially requested those accounts experiencing an increase in calibration-related errors to report the issue to Abbott for a replacement calibrator kit. The 10/7/03 letter requested the accounts to discontinue use and destroy any of the two affected calibrator lots found in inventory. |
Quantity in Commerce | 2677 kits |
Distribution | Nationwide and internationally to Guatemala, Venezuela, Peru, Argentina, Dominican Republic, Canada, Japan, Singapore, Thailand, Korea, Australia, Costa Rica, Panama and Great Britain. |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|